Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
On February 11, the RESILIENCE project took part in the celebration of the International Day of Women and Girls in Science at the Spanish National Center for Cardiovascular Research (CNIC). The event, titled “Let’s Talk About Science: Conference and Panel Discussion,” invited students to discover what scientific research looks like from the inside. More than […]
